Science & Enterprise subscription

Follow us on Twitter

  • A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, b… https://t.co/7Pqc8mJyZ5
    about 2 hours ago
  • New post on Science and Enterprise: First Therapies Selected for Multi-Drug ALS Trial https://t.co/zcM4t6SWxv #Science #Business
    about 2 hours ago
  • A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects o… https://t.co/QK00FJVCzF
    about 8 hours ago
  • New post on Science and Enterprise: Start-Up Targets Extra DNA in Cancer, Raises $46.4M https://t.co/p5AlOJmJnu #Science #Business
    about 8 hours ago
  • An Indiana company is receiving U.S. government and private grants to develop a solar-powered algorithm-controlled… https://t.co/Uj1OLR5vTz
    about 1 day ago

Please share Science & Enterprise

Infographic – What is Crispr?

Crispr explainer

(CB Insights)

9 Feb. 2019. One hot topic we’ve covered almost from the beginning at Science & Enterprise is Crispr — clustered, regularly interspaced short palindromic repeats — a genome editing technique derived from bacterial defense systems. Our first story about the technique dates back to August 2013, but we were also among the early chroniclers of financing for start-up companies commercializing Crispr like Editas Medicine and Crispr Therapeutics, now in full swing developing treatments and licensing their technologies.

Even as Crispr has gained commercial traction and public attention, there’s still a need for a good illustrated introduction to the technique, which or friends at CB Insights published on Thursday, our infographic for this weekend. The chart is part of a larger report on the state of Crispr technology and its applications. Listed below are links to some of our recent stories on Crispr.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...
error

1 comment to Infographic – What is Crispr?